Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
    • Eddie’s Story
    • Video Resources
    • SSF Ambassador Program
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.



    Education, Rare Cancer

    Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis

    May 11, 2026 ayushis Comments Off on Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis
    Two doctors examine X-ray images of a human skull, one in profile and one facing forward, while discussing the results in a well-lit medical setting.

    Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms or legs. In very rare cases, however, it can appear in unusual locations — including the skull and brain region.

    A newly published case report describes a patient diagnosed with primary cranial synovial sarcoma who later developed multiple bone lesions that initially raised concern for metastatic disease. The case highlights how advanced pathology and molecular testing can play a critical role in reaching the correct diagnosis.

    A Rare Form of Synovial Sarcoma

    Primary cranial synovial sarcoma is extremely uncommon. In this case, a woman presented with a swelling in the left parietal region of the skull. Imaging revealed an extradural mass, which was surgically removed with wide margins.

    Pathology testing confirmed a high-grade synovial sarcoma, including the presence of the SS18 gene rearrangement, one of the defining molecular features of synovial sarcoma.

    After surgery, the patient received radiation therapy and remained disease-free for approximately two years.

    New Bone Lesions Raise Concern

    Two years later, the patient developed progressive elbow pain. Scans revealed multiple lytic bone lesions involving the arm, pelvis, sacrum, and femur. PET imaging showed increased metabolic activity consistent with malignancy.

    At first, physicians were concerned these lesions represented metastatic synovial sarcoma.

    However, biopsies from two separate bone sites revealed something unexpected.

    The Importance of Molecular Testing

    Further pathology testing showed the bone lesions were actually consistent with solitary fibrous tumor (SFT) — a different type of rare soft tissue tumor.

    Key findings included:

    • Diffuse STAT6 positivity
    • Absence of SS18 rearrangement

    These molecular and immunohistochemical results helped doctors determine that the lesions were not metastatic synovial sarcoma, but instead represented a second primary tumor.

    The diagnosis was confirmed through multiple pathology reviews and multidisciplinary tumor board evaluation.

    Why This Case Matters

    This rare case highlights several important lessons for the synovial sarcoma community:

    • Synovial sarcoma can appear in rare locations, including the skull
    • New lesions are not always metastatic disease
    • Molecular testing is critical for accurate diagnosis
    • Multidisciplinary sarcoma care helps guide complex treatment decisions

    The case also reinforces the growing importance of combining imaging, pathology, and molecular profiling when evaluating rare cancers.

    For more detailed information, please refer to the original publication. For more information about synovial sarcoma resources and support, please visit our website.

    • cranial synovial sarcoma
    • metastatic synovial sarcoma
    • rare cancer diagnosis
    • rare soft tissue sarcoma
    • sarcoma molecular testing
    • skull synovial sarcoma
    • solitary fibrous tumor
    • SS18 rearrangement
    • STAT6 positivity
    • Synovial Sarcoma
    • Synovial Sarcoma Foundation
    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (5)
    • Children (1)
    • CHOP (3)
    • Clinical Trial (4)
    • Development (12)
    • Dr. Theodore Laetsch (3)
    • Education (27)
    • Europe Expansion (1)
    • Healthcare (13)
    • Latest News (22)
    • Patient Story (1)
    • Programs (1)
    • Rare Cancer (7)
    • Rare Cancer Funding (2)
    • Research (21)
    • SSF Ambassador Program (1)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (7)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A doctor in a white coat with a stethoscope around their neck holds a tablet device, standing in a medical setting with a patient lying on a bed in the background.
      Synovial Sarcoma of the Tibial Nerve: A Case of Diagnostic Ambiguity and Limb Salvage
    • A scientist wearing blue gloves adjusts a microscope slide.
      Can We Reactivate T Cells After TCR-T Therapy Stops Working?
    • Hands wearing blue nitrile gloves draw liquid from a small glass vial into a syringe, with a rack of test tubes in the background.
      Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    Tags

    #AYACancer #CancerResearch #CaseReport #CellTherapy #ClinicalTrials #Immunotherapy #KnowYourOptions #MAGEA4 #MolecularDiagnostics #NYESO1 #PatientAdvocacy #RareCancer #RareDisease #Sarcoma #SarcomaAwareness #SoftTissueSarcoma #SS18SSX #SynovialSarcoma #SynovialSarcomaFoundation #TumorBoard Afami-cel Afamitresgene autoleucel Cancer Research CHOP immunotherapy MAGE-A4 synovial sarcoma NY-ESO-1 synovial sarcoma precision medicine Rare Cancer rare cancer research rare soft tissue sarcoma research sarcoma research sarcoma treatment soft tissue sarcoma Synovial Sarcoma synovial sarcoma biomarker testing synovial sarcoma diagnosis Synovial Sarcoma Foundation synovial sarcoma immunotherapy synovial sarcoma treatment T-Cell Therapy targeted therapy TCR Therapy TECELRA

    Related posts

    A scientist wearing blue gloves adjusts a microscope slide.
    Clinical Trial, Development

    Can We Reactivate T Cells After TCR-T Therapy Stops Working?

    November 3, 2026 ayushis Comments Off on Can We Reactivate T Cells After TCR-T Therapy Stops Working?

    A new pilot trial at Northwestern University is asking one of the most important questions in synovial sarcoma treatment: when TCR-T therapy stops working, are the T cells truly gone, or can they be brought back to life? Background: The Promise and the Limit of TCR-T Therapy TCR-T cell therapy represents a major advance for […]

    Hands wearing blue nitrile gloves draw liquid from a small glass vial into a syringe, with a rack of test tubes in the background.
    Latest News, Synovial Sarcoma Registry

    Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    October 28, 2026 ayushis Comments Off on Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    A new study in Advanced Science (October 12, 2026) shows what becomes possible when patients donate tumor tissue and researchers pair it with detailed clinical and genetic data. The same idea drives the Synovial Sarcoma Registry and Biorepository, and every patient who joins makes the next study possible. What the study found Over ten years, […]

    Close-up of blue gloved hands adjusting a microscope with two visible objective lenses, focusing on a glass slide in a laboratory setting.
    Education, Research

    The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma

    September 14, 2026 ayushis Comments Off on The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma

    A new study published in PLOS One by Ji-Yong Sung, Jin-Hong Kim, and Yi-Jun Kim from Seoul National University and Ewha Womans University, South Korea, examines a type of cell found in the tissue surrounding tumors, called cancer-associated fibroblasts (CAFs), and asks whether they can predict how a sarcoma patient will respond to immunotherapy. What […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    1025 Thomas Jefferson St. NW, Suite W-3200, Washington DC 20007
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch